These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Breitkopf K; Lahme B; Tag CG; Gressner AM Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340 [TBL] [Abstract][Full Text] [Related]
4. [Expression of connective tissue growth factor in progressive muscular dystrophy]. Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854 [TBL] [Abstract][Full Text] [Related]
5. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy. Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547 [TBL] [Abstract][Full Text] [Related]
7. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216 [TBL] [Abstract][Full Text] [Related]
8. Intramuscular renin-angiotensin system is activated in human muscular dystrophy. Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes. Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676 [TBL] [Abstract][Full Text] [Related]
10. Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes. Marra F; Bonewald LF; Park-Snyder S; Park IS; Woodruff KA; Abboud HE J Cell Physiol; 1996 Mar; 166(3):537-46. PubMed ID: 8600157 [TBL] [Abstract][Full Text] [Related]
11. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver. Roth S; Schurek J; Gressner AM Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759 [TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950 [TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study. Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028 [TBL] [Abstract][Full Text] [Related]
18. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744 [TBL] [Abstract][Full Text] [Related]